These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15000468

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.
    Lamoudi L, Chaumeil JC, Daoud K.
    Drug Dev Ind Pharm; 2012 May; 38(5):515-20. PubMed ID: 21978389
    [Abstract] [Full Text] [Related]

  • 23. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
    Rahmouni M, Lenaerts V, Massuelle D, Doelker E, Johnson M, Leroux JC.
    Pharm Dev Technol; 2003 May; 8(4):335-48. PubMed ID: 14601958
    [Abstract] [Full Text] [Related]

  • 24. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S, Khan GM, Jan SU, Shah K, Hussain A, Khan H, Khan H, Khan H, Khan KA.
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Sustained release characteristics of tablets prepared with mixed matrix of sodium carrageenan and chitosan: effect of polymer weight ratio, dissolution medium, and drug type.
    Bani-Jaber A, Al-Ghazawi M.
    Drug Dev Ind Pharm; 2005 Mar; 31(3):241-7. PubMed ID: 15830719
    [Abstract] [Full Text] [Related]

  • 29. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y, Khanvilkar KH, Moore AD, Hilliard-Lott M.
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [Abstract] [Full Text] [Related]

  • 30. Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium.
    Roberts M, Pulcini L, Mostafa S, Cuppok-Rosiaux Y, Marchaud D.
    Pharm Dev Technol; 2015 Jun; 20(4):507-12. PubMed ID: 24354893
    [Abstract] [Full Text] [Related]

  • 31. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN, Schnaare RL, Sugita ET, Schwartz JB.
    Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR Imaging.
    Zahoor FD, Mader KT, Timmins P, Brown J, Sammon C.
    Mol Pharm; 2020 Apr 06; 17(4):1090-1099. PubMed ID: 32069060
    [Abstract] [Full Text] [Related]

  • 37. Formulation development and optimization of bilayer tablets of aceclofenac.
    Dey S, Mahanti B, Khila S, Mazumder B, Gupta SD.
    Expert Opin Drug Deliv; 2012 Sep 06; 9(9):1041-50. PubMed ID: 22788786
    [Abstract] [Full Text] [Related]

  • 38. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH, Mahrous GM, Ibrahim MA, Sakr A.
    Pharm Dev Technol; 2013 Sep 06; 18(5):971-81. PubMed ID: 21639691
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
    Saeidipour F, Mansourpour Z, Mortazavian E, Rafiee-Tehrani N, Rafiee-Tehrani M.
    Eur J Pharm Biopharm; 2017 Dec 06; 121():61-72. PubMed ID: 28951063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.